Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Small Cap

Small Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan
August 22, 7:10 PM
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery…

BLTE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks
  • Small Cap

Geron Commences Initial-Stage Rare Blood Cancer Combination Study

By Ragothaman Srinivasan
August 22, 6:22 PM
Geron Corporation (NASDAQ: GERN) has dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).

GERN

Read More
2 minute read
  • Cannabis
  • ETFs
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Cannabis ETF Makes Bold Bet On Legalization, Reversing Stance On U.S. Marijuana Assets

By Joana Scopel
August 22, 5:55 PM
ETFMG Alternative Harvest ETF (NYSE Arca: MJ), an exchange-traded fund specializing mainly in Canadian cannabis companies and ancillary marijuana businesses, will begin to include U.S.-based marijuana multistate operators.

CGC

Read More
3 minute read
  • Entertainment
  • General
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories

O.G. Meme MoviePass Is Making A Comeback Fit For Scorsese: Subscriptions, Waitlists And More

By Chris Katje
August 22, 5:41 PM
Coming back from the cinematic graveyard is MoviePass, a subscription movie service for the movie theater segment that could have been years ahead of its time. Here are the new details and when you can sign up for the new launch.

AMC

Read More
2 minute read
  • General
  • Real Estate
  • Small Cap

The U.S. City With The Highest Rent Growth May Surprise You. Hint: NYC and LA Don’t Crack The Top 5

By AJ Fabino
August 22, 5:00 PM
After a minor slowdown in rent rise in June, the July National Index from Zumper indicated a return to significant price hikes.

BAC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

Why Is This Analyst Optimist Over Absolute Software, Paycor, Zuora Results This Week?

By Anusuya Lahiri
August 22, 4:00 PM
Needham analyst Scott Berg acknowledged that June-quarter earnings would conclude this week while July-quarter earnings fire up with five…

ABST

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Why Pharvaris Shares Are Plummeting Today?

By Vandana Singh
August 22, 3:45 PM
The FDA verbally placed a clinical hold on Pharvaris NV’s (NASDAQ:PHVS) PHA121 in the U.S. under two Pharvaris Investigational New Drug (IND)…

PHVS

Read More
3 minute read
  • Media
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Could Bed Bath & Beyond Declare Bankruptcy? These 2 Recent Developments Suggest Yes

By Chris Katje
August 22, 3:36 PM
Retailer Bed Bath & Beyond (NASDAQ: BBBY) has been one of the bigger stock storylines of 2022.

BBBY

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Turnaround For This Cancer Genetics Testing Firm Could Take Years, Analyst Says While Downgrading Stock

By Vandana Singh
August 22, 3:29 PM
Needham has downgraded NeoGenomics Inc (NASDAQ:NEO) from Buy to Hold, citing that NEO’s turnaround will likely take several years and believes…

NEO

Read More
3 minute read
  • Entertainment
  • General
  • News
  • Small Cap

House Of The Dragon Or Lord Of The Rings: The Rings Of Power — Which Do Benzinga Followers Prefer?

By Chris Katje
August 22, 3:12 PM
Two of the most anticipated new television series are launching on streaming platforms in August and September.

AMZN

Posts pagination

Previous 1 … 978 979 980 … 1,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service